<DOC>
	<DOC>NCT00523952</DOC>
	<brief_summary>Objective: Assess efficacy and safety of tacrolimus ointment when used in adults with moderate or severe atopic dermatitis. The ointment was applied on the affected skin twice daily for 3 weeks and then once daily until all lesions were cleared</brief_summary>
	<brief_title>Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients</brief_title>
	<detailed_description>The study was a one arm non-comparative study. The only study medication was Tacrolimus ointment 0.1% (Protopic ® 0.1%).</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Male or female, any ethnic group, age ≥16 Moderate to severe atopic dermatitis Has given informed consent Erythroderma Pregnant or breastfeeding Skin infection on the affected area</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>dermatitis, atopic</keyword>
	<keyword>tacrolimus</keyword>
	<keyword>adult</keyword>
</DOC>